News
PASADENA, Calif., April 26, 2025 (GLOBE NEWSWIRE) -- GenVivo, Inc., a clinical-stage biopharmaceutical company pioneering a patented, off-the-shelf vector platform that fights cancer by activating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback